These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 14643157)
1. Vaccine discovery research by reverse engineering. Zagursky R Drug Discov Today; 2003 Nov; 8(21):972-3. PubMed ID: 14643157 [No Abstract] [Full Text] [Related]
2. Translating advances in genomic research into clinical practice: the challenges ahead. Hasnain SE; Banerjee S; Ehtesham NZ Med Princ Pract; 2011; 20(4):392-4. PubMed ID: 21577006 [No Abstract] [Full Text] [Related]
3. Bacterial vaccine discovery: from "brute force" to high selectivity. Grandi G Hum Vaccin; 2010 Nov; 6(11):872-5. PubMed ID: 21084839 [No Abstract] [Full Text] [Related]
4. Animal Models of Human Pathology 2014. Fedele M; Gualillo O; Vecchione A Biomed Res Int; 2015; 2015():721348. PubMed ID: 26247026 [No Abstract] [Full Text] [Related]
5. Immunomics: discovering new targets for vaccines and therapeutics. De Groot AS Drug Discov Today; 2006 Mar; 11(5-6):203-9. PubMed ID: 16580597 [TBL] [Abstract][Full Text] [Related]
6. An expanded role for microbial physiology in metabolic engineering and functional genomics: moving towards systems biology. Nielsen J; Olsson L FEMS Yeast Res; 2002 May; 2(2):175-81. PubMed ID: 12702306 [TBL] [Abstract][Full Text] [Related]
7. Reverse vaccinology in the 21st century: improvements over the original design. Donati C; Rappuoli R Ann N Y Acad Sci; 2013 May; 1285():115-32. PubMed ID: 23527566 [TBL] [Abstract][Full Text] [Related]
8. Process integration challenges in biotechnology yesterday, today and tomorrow. Enfors SO; van der Wielen L; von Stockar U Adv Biochem Eng Biotechnol; 2003; 80():IX-XV. PubMed ID: 12747539 [No Abstract] [Full Text] [Related]
9. Integration of Novel Materials and Advanced Genomic Technologies into New Vaccine Design. Liao W; Zhang TT; Gao L; Lee SS; Xu J; Zhang H; Yang Z; Liu Z; Li W Curr Top Med Chem; 2017; 17(20):2286-2301. PubMed ID: 28240182 [TBL] [Abstract][Full Text] [Related]
10. Reflections on the scope and the future of metabolic engineering and its connections to functional genomics and drug discovery. Bailey JE Metab Eng; 2001 Apr; 3(2):111-4. PubMed ID: 11289787 [TBL] [Abstract][Full Text] [Related]
11. Designing the next generation of vaccines for global public health. Bagnoli F; Baudner B; Mishra RP; Bartolini E; Fiaschi L; Mariotti P; Nardi-Dei V; Boucher P; Rappuoli R OMICS; 2011 Sep; 15(9):545-66. PubMed ID: 21682594 [TBL] [Abstract][Full Text] [Related]
12. DNA technology and vaccines. Brown F Int J Technol Assess Health Care; 1994; 10(4):583-91. PubMed ID: 7843880 [TBL] [Abstract][Full Text] [Related]
13. Two meanings of reverse vaccinology and the empirical nature of vaccine science. Van Regenmortel MH Vaccine; 2011 Oct; 29(45):7875. PubMed ID: 21888936 [No Abstract] [Full Text] [Related]
14. Genomic engineering and the future of medicine. Doudna JA JAMA; 2015 Feb; 313(8):791-2. PubMed ID: 25710652 [No Abstract] [Full Text] [Related]
15. Engineering for the 21st century: synthetic biology. Munnelly K ACS Synth Biol; 2013 May; 2(5):213-5. PubMed ID: 23654289 [TBL] [Abstract][Full Text] [Related]
16. Vaccines based on structure-based design provide protection against infectious diseases. Thomas S; Luxon BA Expert Rev Vaccines; 2013 Nov; 12(11):1301-11. PubMed ID: 24090172 [TBL] [Abstract][Full Text] [Related]
17. Vaccine Research--11th Annual Conference: the role of innate immunity and genomics in vaccine development. O'Brien J IDrugs; 2008 Jul; 11(7):468-70. PubMed ID: 18600588 [No Abstract] [Full Text] [Related]